Literature DB >> 2963060

The coexistence and differentiation of late onset Huntington's disease and Alzheimer's disease. A case report and review of the literature.

R J Moss1, A R Mastri, L J Schut.   

Abstract

The case report presented is clinically compatible with late onset HD. The diagnosis was initially obscured by a lack of family history due to the early death of both parents and siblings. The presence of symptoms at the age of 59 in one offspring is consistent with the intrafamilial transmission of late onset HD disease. The early neuropsychometric data were consistent with the cognitive changes of HD, particularly with the loss of higher cognitive functions, memory and the relative decline in the performance IQ with the preservation of language skills. The psychiatric symptoms of emotional lability and apathy were also congruent with the diagnosis of HD. The atypical features of this patient's course, including progressively severe dementia, seizures and rigidity, may have provided clinical clues to the coexistence of both AD and HD. The absence of caudate atrophy on serial CT scans in this patient, although inconsistent with the gross findings reported on postmortem exam, perhaps could be explained by the 3 1/2-year interval between the last CT scan and death. Further, it has been noted previously that pathological changes tend to lag behind the clinical manifestations of the disease. The pathologic findings on autopsy were confirmatory for the presence of both AD and HD in this patient. Genetic counseling for this family is now most appropriate.

Entities:  

Mesh:

Year:  1988        PMID: 2963060     DOI: 10.1111/j.1532-5415.1988.tb01807.x

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


  5 in total

1.  Molecular cross talk between misfolded proteins in animal models of Alzheimer's and prion diseases.

Authors:  Rodrigo Morales; Lisbell D Estrada; Rodrigo Diaz-Espinoza; Diego Morales-Scheihing; Maria C Jara; Joaquin Castilla; Claudio Soto
Journal:  J Neurosci       Date:  2010-03-31       Impact factor: 6.167

2.  A soluble truncated tau species related to cognitive dysfunction and caspase-2 is elevated in the brain of Huntington's disease patients.

Authors:  Peng Liu; Benjamin R Smith; Eric S Huang; Abhishek Mahesh; Jean Paul G Vonsattel; Ashley J Petersen; Rocio Gomez-Pastor; Karen H Ashe
Journal:  Acta Neuropathol Commun       Date:  2019-07-30       Impact factor: 7.801

Review 3.  Altered Levels and Isoforms of Tau and Nuclear Membrane Invaginations in Huntington's Disease.

Authors:  Marta Fernández-Nogales; José J Lucas
Journal:  Front Cell Neurosci       Date:  2020-01-17       Impact factor: 5.505

Review 4.  Targeting Tau to Treat Clinical Features of Huntington's Disease.

Authors:  Maria Masnata; Shireen Salem; Aurelie de Rus Jacquet; Mehwish Anwer; Francesca Cicchetti
Journal:  Front Neurol       Date:  2020-11-19       Impact factor: 4.003

Review 5.  The Role of Mitochondrial Impairment in Alzheimer´s Disease Neurodegeneration: The Tau Connection.

Authors:  Rodrigo A Quntanilla; Carola Tapia-Monsalves
Journal:  Curr Neuropharmacol       Date:  2020       Impact factor: 7.363

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.